Genetic changes in tumours could predict patients' immunotherapy response

20 April 2021

Scientists led by Dr Kevin Litchfield (UCL Cancer Institute) have identified genetic changes in tumours which could be used to predict if immunotherapy drugs would be effective in individual patients.